MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Validation of a patient/caregiver questionnaire to evaluate nocturnal hypokinesia in Parkinson’s disease

    R. Bhidayasiri, O. Jitkritsadakul, J. Sringean, P. Martinez-Martin, C. Anan, N. Kantachadvanich, R. Chaudhuri, N. Hattori (Bangkok, Thailand)

    Objective: To develop and validate a novel questionnaire to assess various aspects related to problems experienced by PD patients when turning in or getting out…
  • 2018 International Congress

    The validity of the Arabic King’s PD Pain Scale in people with Parkinson’s disease

    H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorofat (Irbid, Jordan)

    Objective: This study aimed to examine the concurrent validity of Arabic translated version of the King's PD Pain Scale (KPPS) in people with Parkinson’s disease…
  • 2018 International Congress

    Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

    G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

    Objective: The aim of our study was to determine the prevalence of dyspnea in a monocentric cohort of 153 non-demented PD patients (mean age: 63.9…
  • 2018 International Congress

    Comorbid REM sleep behavior disorder and impulse control disorder symptoms in early parkinson’s disease: The PPMI cohort

    M.L. Fantini, F. Durif, JC. Corvol, D. Weintraub, C. Caspell-Garcia (Clermont Ferrand, France)

    Objective: To assess the prevalence of Impulse Control Disorder symptoms (ICD) in Parkinson's disease with probable REM sleep behavior disorder (i.e. RBD assessed by questionnaire,…
  • 2018 International Congress

    Visual hallucinations and autonomic burden are inversely associated with physical activity in PD

    J. Hinkle, K. Perepezko, N. Fischer, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

    Objective: To determine the neuropsychiatric and non-motor correlates of reduced physical activity in PD. Background: The motor symptoms of PD interfere with patients’ ability to…
  • 2018 International Congress

    The subthalamic stimulation inhibit bladder contraction by modulating local field potential and monoamine in the medial prefrontal cortex

    T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify the changes in neuronal activity (local field potential and levels of monoamine) of mPFC induced by STN-DBS with relation to…
  • 2018 International Congress

    Objective intestinal dysfunction in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study objectively measured intestinal function, defined by intestinal volume, transit times, and colonic motility patterns in patients with idiopathic REM sleep behaviour disorder…
  • 2018 International Congress

    Freezing of gait recognition in Parkinson’s disease: A subject independent objective method

    V. Rama Raju (Hyderabad, India)

    Objective: In this study, we aim to build an automated-FoG-detector for subject-independent. After extracting enormously relevant features, we apply variance detection-techniques to identify-FoG-events. Background: Gait…
  • 2018 International Congress

    Examination of paravertebral muscular force in camptocormia

    R. Wolke, N. Margraf, J. Kuhtz-Buschbeck, G. Deuschl (Kiel, Germany)

    Objective: To measure the force of paravertebral muscle of PD patients with camptocormia compared to PD patients without camptocormia and healthy controls to assess the…
  • 2018 International Congress

    No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

    F. Hopfner, S. Müller, D. Steppat, J. Miller, N. Schmidt, K.P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. Schulz, A. Spottke, A. Storch, C. Trenkwalder, G. Deuschl, G. Kuhlenbäumer (Kiel, Germany)

    Objective: We measured NMDA antibodies in a large, well phenotyped sample of Parkinson patients without and with cognitive impairment (n = 297) and controls (n…
  • « Previous Page
  • 1
  • …
  • 1174
  • 1175
  • 1176
  • 1177
  • 1178
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley